Axbio Showcases AI-Powered Multi-Omics Solutions for Wellness and Longevity at BIOHK 2024

Hong Kong, September 14, 2024 – Axbio Inc., as a leader in next-generation clinical diagnostics and AI-driven healthcare solutions, made a significant impact at BIOHK 2024, the premier international biotechnology convention held at the Hong Kong Convention and Exhibition Centre. The event gathered global leaders, innovators, and stakeholders from the biotech and life sciences industries to explore the latest advancements and foster strategic collaborations.

Dr. Nikolay Sergeev, VP of Applications at Axbio, delivered an insightful presentation titled "AI-Enhanced Multi-Omics Profiling for Wellness and Longevity." His talk delved into how AI-powered analytics can integrate genetic profiling with biological age estimation to provide a comprehensive assessment of aging drivers in individuals. Dr. Sergeev highlighted Axbio's latest advancements in multi-omics data integration and AI-driven biomarker discovery, emphasizing their potential to revolutionize precision medicine and personalized longevity interventions.

“We are at the forefront of a paradigm shift in healthcare, where AI-driven insights into multi-omics data can empower individuals with actionable recommendations for better longevity and wellness,” said Dr. Sergeev. “Axbio's cutting-edge technology aims to bridge the gap between research and clinical applications, making advanced health monitoring more accessible and impactful.”

Axbio also participated in BIOHK 2024's One2One Partnering program, engaging with potential collaborators, investors, and industry experts to explore new business opportunities and strategic partnerships. With a strong presence at the conference, Axbio reaffirmed its commitment to advancing biotechnology through AI-powered solutions, positioning itself as a key player in the future of precision health.

Looking ahead, Axbio will continue to drive innovation in clinical diagnostics, multi-omics analysis, and AI-powered health solutions, fostering global collaborations to bring cutting-edge technology to the forefront of personalized medicine.

For more information about Axbio's technologies and partnerships, visit www.axbio.com.